Quercetin

Quercetin is a flavonol, a subclass of the flavonoid group of plant polyphenols ^[2]. Its chemical name reflects five hydroxyl groups arranged on the flavone ring system, giving the formula C15H10O7 ^[2]. In plants it usually exists bound to sugars as glycosides rather than in its free aglycone form, and the particular sugar attached affects how well the compound is absorbed when eaten ^[1]. The name derives from the Latin word for an oak forest, reflecting its plant origins.

Quercetin is one of the most common flavonoids in the human diet, present in many fruits, vegetables, leaves, and grains ^[1][2]. Especially rich sources include capers, onions, particularly red onions, kale, apples, berries such as cranberries, buckwheat, and various herbs and teas. Because these foods are widely eaten, quercetin makes up a meaningful share of everyday flavonoid intake, most of it consumed as the naturally occurring glycosides ^[1].

In the laboratory, quercetin shows strong antioxidant and anti-inflammatory activity and has been investigated for a long list of possible effects, including on cardiovascular health, blood pressure, cancer cells, allergy, and infection ^[2]. Translating these findings to people has proven difficult, largely because quercetin is poorly bioavailable: taken by mouth, only a small fraction is absorbed, and what does enter the body is rapidly transformed by the liver and gut into conjugated metabolites that differ from the parent molecule ^[1][2]. Reviews of the human evidence conclude that, despite the promising test-tube data, oral quercetin has not reliably produced the hoped-for clinical benefits, and researchers continue to explore delivery systems and formulations intended to improve its absorption ^[1][2].

Quercetin is sold as a dietary supplement, commonly in the free aglycone form and sometimes paired with agents said to aid its absorption. In the United States, high-purity quercetin has been recognized as generally recognized as safe for use in certain foods, and reviews of its safety generally describe it as well tolerated when consumed in ordinary dietary amounts ^[3]. Regulators, however, have not authorized health claims presenting it as a treatment for disease; European and United States authorities have found insufficient high-quality evidence to support such claims, and manufacturers have been warned against marketing it as a cure ^[3]. Safety questions focus mainly on the effects of concentrated, long-term supplement use rather than on quercetin in food ^[3].

Quercetin is a plant flavonoid consumed widely in foods and generally well tolerated as a supplement, though the safety of high-dose, long-term use is not well characterized. It inhibits CYP3A4 and P-glycoprotein and can alter blood levels of many medications, including some chemotherapy agents, cyclosporine, and anticoagulants. High intravenous doses in older studies were linked to kidney toxicity, so caution is warranted in people with renal impairment.

Quercetin is a naturally occurring flavonol, one of the most abundant polyphenols in the human diet, and its chemistry was characterized during the early development of flavonoid science; its name derives from the Latin quercetum, meaning oak forest. For much of the twentieth century it was studied chiefly as a dietary antioxidant and plant pigment found in onions, apples, capers, berries and tea. Its scientific profile changed markedly in 2015, when researchers at the Mayo Clinic and Scripps identified quercetin, in combination with the cancer drug dasatinib, as the founding senolytic combination, a pairing shown to selectively clear senescent cells implicated in aging and chronic disease.

This discovery propelled quercetin into first-in-human senolytic trials; a 2019 pilot study reported that dasatinib plus quercetin reduced the burden of senescent cells in patients with diabetic kidney disease, and further early trials have since explored the combination in idiopathic pulmonary fibrosis and Alzheimer's disease. Quercetin itself is sold as a dietary supplement and has not been approved to treat any disease.

Quercetin has become one of the most talked-about molecules in aging research, celebrated as half of the original senolytic combination that helped launch an entire field. Scientists find it compelling because, paired with dasatinib, it can selectively clear worn-out senescent cells, and a landmark 2019 trial provided the first direct human evidence that such treatment actually reduces senescent cell burden in the body.

Beyond longevity science it is valued as a versatile dietary flavonoid with antioxidant and anti-inflammatory activity, and as a zinc ionophore that helps carry zinc into cells. Intellectual honesty is important here: quercetin is poorly absorbed when taken orally, its circulating metabolites behave differently from the parent molecule, and it has not been shown in humans to treat or prevent any disease. As an abundant, well-studied nutrient with a starring role in cutting-edge senolytic research, it nonetheless remains genuinely exciting and worth watching.